JERRY JOSEPH: Open Payments
NPI 1467869727 · FRANKLIN LAKES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,643 in 181 payments from 18 companies in 2025. Trend: 2023 $1,444 · 2024 $1,865 · 2025 $2,643
Food & beverage: $2,628Education: $15
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 25 | $398 |
| Alkermes, Inc. | 19 | $360 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $231 |
| Janssen Pharmaceuticals, Inc | 13 | $220 |
| Otsuka America Pharmaceutical, Inc. | 14 | $206 |
| Teva Pharmaceuticals USA, Inc. | 12 | $202 |
| Vanda Pharmaceuticals Inc. | 10 | $198 |
| E.R. Squibb & Sons, L.L.C. | 14 | $197 |
| ABBVIE INC. | 32 | $149 |
| Lundbeck LLC | 6 | $111 |
Products named: INGREZZA, ARISTADA, CAPLYTA, REXULTI, INVEGA SUSTENNA, FANAPT, COBENFY, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
